Government Exhibit 940I

The proposed chart used total sales revenue and the sample's highest price per weight to estimate drug quantities. On Day 10, the court required the sample, an explanation of the sampling program and data beyond the sample so the exercise could be replicated. The chart remained excluded after the government declined to provide the underlying data, and the court closed the issue without further briefing.